UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$1.51B |
| 2 |
Accenture
ACN
|
+$1.43B |
| 3 |
Linde
LIN
|
+$1.18B |
| 4 |
Prologis
PLD
|
+$1.06B |
| 5 |
Microsoft
MSFT
|
+$908M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$818M |
| 2 |
Lam Research
LRCX
|
+$784M |
| 3 |
Blackrock
BLK
|
+$737M |
| 4 |
Meta Platforms (Facebook)
META
|
+$506M |
| 5 |
UBS Group
UBS
|
+$399M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.2% |
| 2 | Financials | 12.03% |
| 3 | Healthcare | 11.96% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Collegium Pharmaceutical
COLL
$956M
| $2.29M | ﹤0.01% |
59,326
-9,984
| -14% | -$356K |
|
1952
Enovix
ENVX
$1.03B
| $2.29M | ﹤0.01% |
280,413
-19,283
| -6% | -$200K |
|
1953
Travere Therapeutics
TVTX
$5.78B
| $2.28M | ﹤0.01% |
163,175
-15,574
| -9% | -$162K |
|
1954
QCR Holdings
QCRH
$1.7B
| $2.28M | ﹤0.01% |
30,820
-2,902
| -9% | -$206K |
|
1955
Pennant Group
PNTG
$1.36B
| $2.28M | ﹤0.01% |
63,865
-3,293
| -5% | -$101K |
|
|
RWT
1956
Redwood Trust
RWT
$594M
| $2.25M | ﹤0.01% |
291,563
+79,094
| +37% | +$577K |
|
1957
Edgewise Therapeutics
EWTX
$4.73B
| $2.25M | ﹤0.01% |
84,294
+4,426
| +6% | +$88K |
|
1958
Par Pacific Holdings
PARR
$3.32B
| $2.25M | ﹤0.01% |
127,732
+8,844
| +7% | +$198K |
|
1959
Kaspi.kz JSC
KSPI
$17.2B
| $2.25M | ﹤0.01% |
21,206
+16,456
| +346% | +$2.04M |
|
|
GLDD
1960
DELISTED
Great Lakes Dredge & Dock
GLDD
| $2.25M | ﹤0.01% |
213,330
+13,203
| +7% | +$123K |
|
1961
Baytex Energy
BTE
$2.92B
| $2.24M | ﹤0.01% |
755,172
-127,893
| -14% | -$435K |
|
1962
US Physical Therapy
USPH
$1.22B
| $2.23M | ﹤0.01% |
26,366
-3,817
| -13% | -$339K |
|
1963
Intercorp Financial Services
IFS
$6.55B
| $2.23M | ﹤0.01% |
85,200
| – | – |
|
1964
Frontline
FRO
$8.85B
| $2.23M | ﹤0.01% |
97,411
-15,298
| -14% | -$360K |
|
1965
TeraWulf
WULF
$8.52B
| $2.22M | ﹤0.01% |
473,415
-68,229
| -13% | -$310K |
|
1966
Core Laboratories
CLB
$521M
| $2.21M | ﹤0.01% |
119,443
+133
| +0.1% | +$2.67K |
|
1967
Rocket Pharmaceuticals
RCKT
$394M
| $2.21M | ﹤0.01% |
119,633
+1,561
| +1% | +$32K |
|
1968
Dorian LPG
LPG
$1.96B
| $2.2M | ﹤0.01% |
64,038
-11,566
| -15% | -$438K |
|
|
ARR
1969
Armour Residential REIT
ARR
$2.36B
| $2.2M | ﹤0.01% |
108,029
+32,351
| +43% | +$659K |
|
1970
iShares Russell 2000 ETF
IWM
$81.9B
| $2.2M | ﹤0.01% |
9,970
| – | – |
|
|
SHOE
1971
Shoe Station Group
SHOE
$428M
| $2.2M | ﹤0.01% |
50,069
+6,946
| +16% | +$284K |
|
1972
Aurinia Pharmaceuticals
AUPH
$2.11B
| $2.19M | ﹤0.01% |
298,454
-27,428
| -8% | -$170K |
|
|
LGF.B
1973
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $2.18M | ﹤0.01% |
315,525
-13,260
| -4% | -$99.6K |
|
1974
MarineMax
HZO
$788M
| $2.18M | ﹤0.01% |
61,879
+4,548
| +8% | +$148K |
|
1975
FB Financial Corp
FBK
$3.04B
| $2.17M | ﹤0.01% |
46,225
-6,934
| -13% | -$312K |
|
Similar funds
UBS AM's Q3 2024 Portfolio in Review
As of Q3 2024, UBS AM held 2,899 positions worth $389B, up 12% from $349B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
UBS AM deployed $20.6B of net new capital in Q3 2024, opening 104 new positions and adding to 979 existing holdings. Its largest new stake was Cemex: 31,204,197 shares worth $190M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $818M trimmed.
- UBS AM's largest Q3 2024 buy was Cemex: 31,204,197 shares worth $190M.
- UBS AM added most to Pinduoduo in Q3 2024, an estimated $1.51B increase.
- UBS AM's biggest Q3 2024 reduction was Alphabet (Google) Class A, cutting an estimated $818M.
- UBS AM fully exited Vanguard Russell 1000 Growth ETF in Q3 2024, selling an estimated $128M.
- UBS AM's ten largest holdings make up 29% of its $389B portfolio in Q3 2024.
- UBS AM opened 104 new positions and closed 100 in Q3 2024.
- UBS AM's portfolio value rose 12% quarter-over-quarter to $389B.
Based on UBS AM's 13F filing for Q3 2024, filed 14 Nov 2024.